Gian-Marco Rinaldi Diaz de la Cruz
Directeur/Membre du Conseil chez NLS PHARMACEUTICS AG
Fortune : 37 890 $ au 31/05/2024
Postes actifs de Gian-Marco Rinaldi Diaz de la Cruz
Sociétés | Poste | Début | Fin |
---|---|---|---|
NLS PHARMACEUTICS AG | Directeur/Membre du Conseil | 17/06/2021 | - |
Independent Dir/Board Member | 17/06/2021 | - | |
Finad AG
Finad AG Investment Trusts/Mutual FundsMiscellaneous Finad AG engages in fund management activities. It offers asset management services. The company was founded by Alfred Schwarzenbach and Miguel Steiner in 1976 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | 01/01/2009 | - |
Historique de carrière de Gian-Marco Rinaldi Diaz de la Cruz
Anciens postes connus de Gian-Marco Rinaldi Diaz de la Cruz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Clariden Leu AG | Corporate Officer/Principal | 01/01/2007 | 01/01/2009 |
Formation de Gian-Marco Rinaldi Diaz de la Cruz
University of Zurich | Graduate Degree |
Fachhochschule Nordwestschweiz FHNW | Graduate Degree |
Applied Sciences & Arts Northwestern Switzerland University | Graduate Degree |
Statistiques
Internationale
Suisse | 7 |
Opérationnelle
Graduate Degree | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 2 |
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NLS PHARMACEUTICS AG | Health Technology |
Entreprise privées | 2 |
---|---|
Finad AG
Finad AG Investment Trusts/Mutual FundsMiscellaneous Finad AG engages in fund management activities. It offers asset management services. The company was founded by Alfred Schwarzenbach and Miguel Steiner in 1976 and is headquartered in Zurich, Switzerland. | Miscellaneous |
Clariden Leu AG | Finance |